{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Possibly Marketed Outside US
Source:
M016
(2024)
Source URL:
First approved in 2011
Source:
21 CFR 352
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2011)
Source URL:
First approved in 2011
Source:
21 CFR 352
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 346
(2011)
Source URL:
First approved in 2011
Source:
21 CFR 346
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 333A
(2011)
Source URL:
First approved in 2011
Source:
21 CFR 333A
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
Equine with Epiitalis for Joint and Cartilage Matrix Support by American Aquatic Testing, Inc.
(2011)
Source URL:
First approved in 2011
Source:
Equine with Epiitalis for Joint and Cartilage Matrix Support by American Aquatic Testing, Inc.
Source URL:
Class:
MIXTURE
Status:
First approved in 2011
Source:
21 CFR 358A
Source URL:
Class:
MIXTURE
Status:
US Approved Rx
(2011)
Source:
BLA125370
(2011)
Source URL:
First approved in 2011
Source:
BLA125370
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2011)
Source:
BLA125377
(2011)
Source URL:
First approved in 2011
Source:
BLA125377
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2021)
Source:
BLA761179
(2021)
Source URL:
First approved in 2011
Source:
Erwinaze
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2011)
First approved in 2011
Class:
PROTEIN
